Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$230.25
+1.73%
Alpha Vantage · 11/6/2026
Adjusted daily closes · 252 observations · as of Nov 6, 2026
1 month
+5.9%
3 months
+10.2%
6 months
+35.0%
1 year
+10.1%
Year to date
+1.2%
52-week range
$161.29 – $240.59
Latest reported period: Sep 25, 2026
Market cap
$161.99B
P/E
37.4
P/B
3
P/S
6.3
Revenue
$25.61B
Net income
$4.33B
Diluted EPS
6.11
Gross margin
58.60%
Net margin
16.90%
Return on equity
8.20%
Total debt
$26.48B
Cash
$5.68B
Free cash flow
$5.75B
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Sep 25, 2026 | $6.55B | $1.24B | 58.50% | 18.80% | $1.63B |
| Jun 26, 2026 | $6.27B | $870M | 57.60% | 13.90% | $1.27B |
| Mar 27, 2026 | $5.95B | $1.03B | 60.30% | 17.30% | $1.09B |
| Dec 31, 2025 | $6.84B | $1.2B | 58.00% | 17.50% | $1.77B |
| Sep 26, 2025 | $6.05B | $908M | 58.20% | 15.00% | $1.37B |
| Jun 27, 2025 | $5.94B | $555M | 59.30% | 9.30% | $1.09B |
| Mar 28, 2025 | $5.74B | $954M | 61.20% | 16.60% | $1.06B |
| Dec 31, 2024 | $6.54B | $1.09B | 59.50% | 16.60% | $1.5B |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Danaher (DHR) has seen its stock fair value increase due to analysts raising price targets, with several now between US$260 and US$275. This optimism is driven by the company's 2027 core growth projections, Q3 2026 performance, and potential for improved margins and organic growth. The revised fair value estimate for Danaher has moved from US$244.14 to US$259.90.
Original sourceDanaher director Alan G. Spoon acquired 193 phantom shares on October 30, 2026, under the company's Non-Employee Directors Deferred Compensation Plan. These phantom shares, which are equivalent to common stock upon distribution, were priced at Danaher's closing price of $232.23 per share on the transaction date. This acquisition increased Spoon's total holdings to 31,236 phantom shares, in which he is fully vested.
Original sourceDanaher Corporation director Elias A. Zerhouni was awarded 199 phantom shares on October 30, 2026, priced at $232.23 per share, increasing his total holdings to 18,908 phantom shares. These phantom shares, deferred under the Non-Employee Directors Deferred Compensation Plan, are fully vested and convert into Danaher common stock on a one-for-one basis upon distribution.
Original sourceWall Street Zen upgraded Danaher (DHR) stock from Hold to Buy on October 26, contributing to a bullish analyst view. This upgrade, along with several price target increases from firms like TD Cowen and JPMorgan, followed Danaher's stronger-than-expected third-quarter results. While respiratory demand remains a headwind, the company improved its 2026 adjusted earnings outlook and showed stronger execution in life sciences, biotechnology, and diagnostics.
Original source